OpenAI, Anthropic, SpaceX, and Stripe are reportedly among the top tech firms slated for initial public offerings (IPOs) in 2026. While “unicorns” are startups valued over $1 billion, 2026 could see the emergence of “hectocorns,” companies valued at over $100 billion, hitting stock markets in the US and Europe. This marks a significant shift as these titans prepare to go public, signaling a new era in tech investment.
OpenEvidence, the medical information database, has doubled its valuation to $12 billion since its previous funding round in October, even as competition from model developers increases.
A new wave of entrepreneurship centered around fractional executives is redefining self-employment. Since 2018, demand for specialized part-time executive talent has tripled, with roles like CFO, CMO, and CEO leading the charge. This shift is driven by a combination of layoffs freeing up skilled professionals and companies seeking cost-effective, flexible alternatives to full-time hires. Fractional work, favored particularly by women due to its flexibility, addresses caregiving needs and remote work preferences. Experts see this trend as enduring, reflecting a broader shift towards unbundled, flexible roles accelerated by the pandemic and evolving workforce values. Once perceived as a backup option, fractional work now symbolizes expertise and agility, attracting established companies that prefer temporary, specialized help over permanent hires. These fractional roles are carving out a permanent niche alongside traditional employment, favored by both startups and established organizations navigating today’s volatile business environment.
Michael Burry, known for his role in "The Big Short," praised Ben Affleck as "clearly a smart guy" after Affleck criticized AI chatbots and questioned the heavy investment in data centers. Their shared skepticism highlights growing concerns about the current enthusiasm surrounding AI technologies.
Cybersecurity startups attracted a surge in funding during 2025, reaching the highest level in three years. Investment topped $18 billion, marking a 26% increase over 2024, driven largely by large funding rounds for AI-centered security firms. Despite a slight drop in the number of deals, the amount raised grew significantly, especially at the early stages where $7.5 billion was invested—a 63% increase fueled by AI-security innovations. U.S.-based companies dominated the market, securing 74% of total deals and sizable exits. Highlight deals included Cyera's near-billion-dollar funding rounds and Google's planned $32 billion acquisition of cloud security firm Wiz. The year also featured major IPOs and acquisitions, signaling strong confidence in cybersecurity's growth and resilience.
ClickHouse, a challenger to Snowflake and Databricks in the data analytics space, has secured a $400 million investment round led by Dragoneer, boosting its valuation to $15 billion.
Shares of ASML surged following TSMC's announcement of an optimistic financial forecast for 2026, highlighting growing investor confidence in semiconductor leaders.
OpenAI has started incorporating advertisements within ChatGPT as a strategy to boost its revenue. This decision follows significant financial commitments totaling $1.4 trillion and anticipates a potential IPO in the near future.
In 2025, global venture capital funding for fintech startups reached $51.8 billion, marking a 27% increase from $40.8 billion in 2024, propelled by significant late-stage investments. Despite a 23% decline in the number of deals to 3,457, the total funding surpassed pre-pandemic levels. Major investments highlighted include Polymarket's $2 billion round, Binance's $2 billion infusion, and Kalshi's $1 billion Series E funding. Experts attribute the healthier funding environment to a market reset post-2022, with a focused investment approach favoring quality over quantity, particularly in areas like AI and stablecoins. This marks a shift from the rapid, less selective funding seen in 2021–2022 when fintech benefited from pandemic-driven digital adoption and low interest rates.
Washington's healthcare debate has persisted for decades, rooted in deep partisan divides and complex stakeholder interests. Since President Harry Truman's unsuccessful push in 1945 for a national healthcare program, 13 presidents have grappled with defining the government's role amid escalating healthcare costs that now consume nearly 18% of the U.S. economy. The Affordable Care Act (ACA), passed in 2010 without Republican support, remains a focal point of contention. Recent expiration of subsidies under the ACA has reignited old disagreements, with Democrats advocating for more comprehensive coverage and Republicans focusing on cost control, often influenced by medical industry lobbying. Efforts to find middle ground continue amidst political stalemate, industry pushback, and shifting public opinion that increasingly favors the ACA. Despite various proposals, including revisiting the public option, meaningful reform faces significant hurdles as lawmakers navigate the politically charged environment.
